Trials / Not Yet Recruiting
Not Yet RecruitingNCT06583564
The Prognosis Effect of Indocyanine Green (ICG) Fluorescence Guided Surgery on Disease-free Survival (DFS) of Stage III Colorectal Cancer
A Single Center Randomized Controlled Study of the Prognosis After Indocyanine Green Fluorescence-guided Radical Surgery in Colorectal Cancer Patients of Stage III
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 192 (estimated)
- Sponsor
- Shanghai Tong Ren Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Previous studies of Indocyanine green (ICG) in colorectal surgery have focused on lymphatic mapping, lymph node detection, and the number of harvested lymph nodes. However, relatively few studies have evaluated the outcomes of this imaging technology, especially the prognosis following of colorectal cancer resection. The present study assessed the prognosis of stage III colorectal cancer patients following ICG fluorescence-guided surgery as compared to conventional surgery without the use of ICG Fluorescence imaging
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ICG lymphangiography procedure | All patients underwent standard complete mesocolic excision (CME) or total mesorectal excision (TME) with curable purpose using ICG lymphangiography procedure |
Timeline
- Start date
- 2024-09-27
- Primary completion
- 2025-03-31
- Completion
- 2025-03-31
- First posted
- 2024-09-04
- Last updated
- 2024-09-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06583564. Inclusion in this directory is not an endorsement.